Skyscape Web Viewer : Fischbach's Manual of Laboratory and Diagnostic Tests : Main Index

View All
Pretest Phase: Elements of Safe, Effective, Informed Care
Prevalence Clinical Value of a Test Grading Guidelines for Scientific Evidence Diagnostic Testing Overview of Laboratory and Diagnostic Testing
Primary septicemic plague infection, diagnosis of
Privacy Diagnostic Testing Ethics and the Law Elements of Safe, Effective, Informed Care Throughout the Testing Process Patient's Bill of Rights and Patient Responsibilities
Proctoscopy, flexible
Professional practice parameters
Progesterone Progesterone drug effects on
Progesterone receptor (PR) Cytologic, Histologic, and Genetic Studies Estrogen/Estradiol Receptor (ER), Progesterone Receptor (PR) Histologic (Tissue) Study and DNA Ploidy (Tumor Aneuploidy) Breast Biopsy Cytologic and Histologic Studies Histologic (Tissue) Biopsy Studies
Prognostic markers, tumor Cytologic, Histologic, and Genetic Studies Histologic (Tissue) Biopsy Studies Protein Chemistry Testing/Serum Proteins: Acute-Phase Proteins and Cytokines Useful Information from a Single Biopsy Specimen Cytologic and Histologic Studies Immunodiagnostic Studies Tumor Markers
PPE
PRA
Prebiopsy study, sentinel node
Pregnanetriol, quantitative (24-hour) in urine
Prenatal Diagnosis and Tests of Fetal Well-Being
Prolactin (hPRL) Prolactin (hPRL) drug effects on
Proliferating cell nuclear antigen (PCNA) Cytologic and Histologic Studies Cytologic, Histologic, and Genetic Studies Histologic (Tissue) Biopsy Studies
Proliferative index Cytologic, Histologic, and Genetic Studies Histologic (Tissue) Biopsy Studies Cytologic and Histologic Studies
Prone position Diagnostic Testing Management of Environment Presence of Family or Significant Others Administration of Drugs and Solutions Intratest Phase: Elements of Safe, Effective, Informed Care Positioning for Procedures
Prophylactic antifungals Standard Precautions for Prevention and Control of Infection Safe Practice Domains for Specific Situations
Prophylactic anti-infectives Standard Precautions for Prevention and Control of Infection Safe Practice Domains for Specific Situations
ProstaScint imaging Overview of Monoclonal Antibody Tumor Imaging Prostascint Imaging
Prostate biopsy Cytologic, Histologic, and Genetic Studies Histologic (Tissue) Biopsy Studies Cytologic and Histologic Studies Sentinel Node Location Before Biopsy (Breast, Melanoma)
Prostate cancer nuclear medicine study in tumor markers in oncoprofile in
Prostate-specific antigen (PSA) Prostate-Specific Antigen (PSA) Tumor-Specific and Tumor-Associated Agents Goals of Test Selection with Examples Suggested Age-Specific Prostate-Specific Antigen (PSA) Reference Ranges
Prostatic acid phosphatase (PAP) Acid Phosphatase; Prostatic Acid Phosphatase (PAP) Tumor-Specific and Tumor-Associated Agents
Protamine sulfate test Blood Studies: Hematology and Coagulation Laboratory Tests to Measure Hemostasis Tests of Hemostasis and Coagulation Fibrin Monomers (Protamine Sulfate Test; Fibrin Split Products) Tests for Disseminated Intravascular Coagulation (DIC)
Protected health information (PHI) Elements of Safe, Effective, Informed Care Throughout the Testing Process Patient's Bill of Rights and Patient Responsibilities Diagnostic Testing Ethics and the Law
Protein, CSF (total) drug effects on CSF Total Protein
Protein, urine drug effects on Routine Urinalysis (Ua) and Related Tests Urine Studies Collection of Urine Specimens Long-Term, Timed Urine Specimen (2-Hour, 24-Hour) Urine Protein (Albumin), Qualitative and 24-Hour Urine Testing by Dipstick/Reagent Strip
Protein C Protein C (Pc Antigen) Proteins Involved in Blood Coagulation